Results 191 to 200 of about 2,655 (208)

Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure

Cephalalgia, 2019
Janet H Ford, Shuu-Jiun Wang
exaly  

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

Headache, 2019
Virginia L Stauffer, Sheena K Aurora
exaly  

Galcanezumab rasch und anhaltend wirksam

InFo Neurologie + Psychiatrie, 2021
openaire   +1 more source

Erenumab/fremanezumab/galcanezumab

Reactions Weekly, 2019
openaire   +1 more source

Galcanezumab reduziert Migränetage

InFo Neurologie & Psychiatrie, 2019
openaire   +1 more source

Zulassung für Galcanezumab

DNP - Der Neurologe & Psychiater, 2019
openaire   +1 more source

Galcanezumab in chronic migraine

Neurology, 2018
Holland C Detke, Peter Goadsby, Katherine J Selzler   +2 more
exaly  

Population Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine

Journal of Clinical Pharmacology, 2020
exaly  

Galcanezumab verringert Migräne und Clusterkopfschmerz

Schmerzmedizin, 2020
openaire   +1 more source

Eptinezumab/Galcanezumab

Reactions Weekly
openaire   +1 more source